Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for IDEAYA Biosciences (IDYA) over the last 6 years, with Q3 2025 value amounting to 57.63%.

  • IDEAYA Biosciences' EBITDA Margin changed N/A to 57.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 52.78%, marking a year-over-year increase of 43718500.0%. This contributed to the annual value of 3917.53% for FY2024, which is 34491600.0% down from last year.
  • Per IDEAYA Biosciences' latest filing, its EBITDA Margin stood at 57.63% for Q3 2025.
  • In the past 5 years, IDEAYA Biosciences' EBITDA Margin registered a high of 57.63% during Q3 2025, and its lowest value of 1904.8% during Q4 2024.
  • Over the past 5 years, IDEAYA Biosciences' median EBITDA Margin value was 308.72% (recorded in 2023), while the average stood at 442.65%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first surged by 1337300bps in 2022, then crashed by -10725000bps in 2024.
  • Quarter analysis of 5 years shows IDEAYA Biosciences' EBITDA Margin stood at 637.2% in 2021, then grew by 10bps to 573.6% in 2022, then plummeted by -45bps to 832.3% in 2023, then crashed by -129bps to 1904.8% in 2024, then skyrocketed by 103bps to 57.63% in 2025.
  • Its last three reported values are 57.63% in Q3 2025, 1904.8% for Q4 2024, and 832.3% during Q4 2023.